This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Early Triple Therapy for Type 2 Diabetes

Posted: Wednesday, September 23, 2009

When metformin and a sulfonylurea or a glinide fail to bring Type 2 diabetes under control, adding pioglitazone may do the trick, French research suggests.

Insulin or Metformin Does Not Reduce Inflammatory Biomarkers

Posted: Wednesday, September 16, 2009

In patients with recent onset Type 2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study.

New Buccal Insulin Approved by the FDA but with Conditions

Posted: Wednesday, September 16, 2009

Generex Biotechnology Corporation, an innovator for drug delivery for metabolic diseases through the inner lining of the mouth, announced that the U.S. FDA has granted approval for the treatment use of Oral-lyn™ under the FDA’s Treatment Investigational New Drug (IND) program.

Computerized Insulin Infusion Works in ICU Patients

Posted: Wednesday, September 16, 2009

A computer-aided insulin infusion protocol maintains glucose control in the ICU as effectively as a strict glycemic control protocol, and both of these methods are more effective than conventional treatment, researchers report.

Should Aspirin Be Routine for Type 2’s?

Posted: Wednesday, September 16, 2009

The widespread recommendation for the routine use of low-dose aspirin in primary prevention of cardiovascular events for all patients with Type 2 diabetes should be revisited, experts said at the European Society of Cardiology 2009 Congress.

New Diet Pill from Two Old Drugs

Posted: Wednesday, September 16, 2009

Patients taking a novel diet drug that combines the stimulant phentermine with the anticonvulsant, topiramate lost an average of 37 pounds over a year with significant improvement in a number of cardiovascular risk factors.

Diabetes Vaccine Diamyd® Shows Reduction or Halting Destruction of Beta-Cells 4 Years Later

Posted: Wednesday, September 09, 2009

Diamyd Medical announced last week that the company's 4-year follow-up of Type 1 diabetes patients included in the company's Phase II study shows a clear positive trend.

New Pump CGMS Combo Detects Hypo’s and Turns Off Automatically

Posted: Wednesday, September 09, 2009

This new device, now available in more than 50 countries outside of the United States, can automatically suspend insulin delivery when the device senses that glucose levels have fallen to or below a user-selected threshold.

New Molecule Combats Diabetes and Obesity by Increasing GLP-1

Posted: Wednesday, September 09, 2009

We now have drugs that can replace the GLP-1 hormone and we have drugs that can reduce the destruction of GLP-1. Now we may have a drug that increases the production of GLP-1.

Insulin-Producing Cells Made from Adult Skin Cells

Posted: Wednesday, September 09, 2009

Using skin cells from people with Type 1 diabetes, researchers were able to produce cells that made insulin in response to changing blood sugar levels.